ロード中...
Evolocumab lowers LDL-C safely and effectively when self-administered in the at-home setting
Evolocumab has been shown to consistently reduce low-density lipoprotein cholesterol (LDL-C) across populations. The phase 3 studies included administration in the home-use and in-clinic settings but did not specifically evaluate the feasibility of home-use administration. Two clinical studies enrol...
保存先:
| 出版年: | Springerplus |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4783317/ https://ncbi.nlm.nih.gov/pubmed/27066336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-1892-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|